Alnylam Pharmaceuticals (ALNY) Goodwill & Intangibles (2009 - 2012)
Alnylam Pharmaceuticals (ALNY) reported Goodwill & Intangibles of $145000.0 for Q3 2012, down 54.4% on a YoY basis from $318000.0 in Q4 2011, and down 22.87% quarter-over-quarter from $188000.0 in Q2 2012.
Alnylam Pharmaceuticals (ALNY) Goodwill & Intangibles (2009 - 2012) Analysis & Trends
Alnylam Pharmaceuticals has reported Goodwill & Intangibles for 4 years, with the latest figure at $145000.0 in Q3 2012.
- For the quarter ending Q3 2012, Goodwill & Intangibles fell 54.4% year-over-year to $145000.0; the trailing twelve-month figure through Sep 2012 stood at $145000.0 (down 54.4% YoY), and the FY2011 full-year result was $275000.0, down 38.62% from the prior year.
- Goodwill & Intangibles for Q3 2012 stood at $145000.0, down from $188000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $622000.0 in Q4 2009, with the low at $145000.0 in Q3 2012.
- Historically, Goodwill & Intangibles has averaged $365363.6 across 4 years, with a median of $361000.0 in 2011.
- Annual changes were most pronounced in 2010 — Goodwill & Intangibles decreased 27.97% — and 2012, when it plunged 54.4%.
- Alnylam Pharmaceuticals' Goodwill & Intangibles stood at $622000.0 in 2009, then declined by 27.97% to $448000.0 in 2010, then sank by 38.62% to $275000.0 in 2011, then slumped by 47.27% to $145000.0 in 2012.
- The last three Goodwill & Intangibles figures came in at $145000.0 (Q3 2012), $188000.0 (Q2 2012), and $231000.0 (Q1 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alnylam Pharmaceuticals | 37.04 Bn | 34.03 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 145,000.00 |
| Jun 30, 2012 | 188,000.00 |
| Mar 31, 2012 | 231,000.00 |
| Dec 31, 2011 | 275,000.00 |
| Sep 30, 2011 | 318,000.00 |
| Jun 30, 2011 | 361,000.00 |
| Mar 31, 2011 | 405,000.00 |
| Dec 31, 2010 | 448,000.00 |
| Sep 30, 2010 | 491,000.00 |
| Jun 30, 2010 | 535,000.00 |
| Dec 31, 2009 | 622,000.00 |